New Discovery: Novel Itch Pathway Linking S.Aureus Exotoxin to Itch in AD Patients

    La Roche-Posay
  • Oct 2025
  • 5min

Published in

Cell

ABSTRACT


Highlights:
• S. aureus induces itch and scratch damage with epicutaneous skin exposure
• V8 protease (SspA) is necessary and sufficient for itch during S. aureus exposure
• S. aureus V8 activates mouse and human sensory neurons through PAR1
• PAR1 deficiency or blockade abrogates S. aureus-induced itch and skin damage

 

Summary: 

Itch is an unpleasant sensation that evokes a desire to scratch. The skin barrier is constantly exposed to microbes and their products. However, the role of microbes in itch generation is unknown. Here, we show that Staphylococcus aureus, a bacterial pathogen associated with itchy skin diseases, directly activates pruriceptor sensory neurons to drive itch. Epicutaneous S. aureus exposure causes robust itch and scratch-induced damage. By testing multiple isogenic bacterial mutants for virulence factors, we identify the S. aureus serine protease V8 as a critical mediator in evoking spontaneous itch and alloknesis. V8 cleaves proteinase-activated receptor 1 (PAR1) on mouse and human sensory neurons. Targeting PAR1 through genetic deficiency, small interfering RNA (siRNA) knockdown, or pharmacological blockade decreases itch and skin damage caused by V8 and S. aureus exposure. Thus, we identify a mechanism of action for a pruritogenic bacterial factor and demonstrate the potential of inhibiting V8-PAR1 signaling to treat itch

Get free unlimited access to more articles and resources like this!

L'Oréal Dermatological Beauty Pro is a digital community empowering healthcare professionals to improve their daily practice of dermatology through cutting edge research, science and education on skin and hair care.